Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Breast and Ovarian Cancer”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Very early researchStudy completedNCT03832985
What this trial is testing

Pediatric Reporting of Adult-Onset Genomic Results

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch SyndromeFamilial Hypercholesterolemia
Geisinger Clinic 427
Not applicableLooking for participantsNCT03667417
What this trial is testing

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Who this might be right for
Breast CancersOvarian Cancers
Institut Paoli-Calmettes 5,000
Not applicableStudy completedNCT00735150
What this trial is testing

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

Who this might be right for
Breast CancerOvarian Cancer
Memorial Sloan Kettering Cancer Center 34
Not applicableActive Not RecruitingNCT04145388
What this trial is testing

Family History Study on Cancer Risk

Who this might be right for
Lynch SyndromeColorectal CancerBreast Cancer+3 more
Kaiser Permanente 18,623
Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableLooking for participantsNCT02302742
What this trial is testing

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Who this might be right for
Breast CancerHereditary Breast and Ovarian Cancer
University of Kansas Medical Center 1,500
Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Not applicableStudy completedNCT06184867
What this trial is testing

Choices About Genetic Testing And Learning Your Risk With Smart Technology

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Rutgers, The State University of New Jersey 50
Not applicableLooking for participantsNCT04214210
What this trial is testing

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Who this might be right for
Hereditary CancerBreast CancerOvarian Cancer
University of Basel 228
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 720
Not applicableActive Not RecruitingNCT02653105
What this trial is testing

Women at Risk of Breast Cancer and OLFM4

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Institut Cancerologie de l'Ouest 150
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03304210
What this trial is testing

PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer

Who this might be right for
Peritoneal CarcinomatosisOvarian Cancer Stage IIIBOvarian Cancer Stage IIIC+8 more
University Hospital, Ghent 20
Not applicableLooking for participantsNCT04751435
What this trial is testing

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Who this might be right for
Educational Materials for Genetic TestingBreast CancerOvarian Cancer+3 more
Memorial Sloan Kettering Cancer Center 445
Large-scale testing (Phase 3)Study completedNCT00673335
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
UNICANCER 170
Not applicableActive Not RecruitingNCT02194387
What this trial is testing

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Who this might be right for
Body Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene Mutation+8 more
M.D. Anderson Cancer Center 337
Load More Results